Filing Details
- Accession Number:
- 0000904454-16-001183
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-04-25 16:34:21
- Reporting Period:
- 2016-04-21
- Filing Date:
- 2016-04-25
- Accepted Time:
- 2016-04-25 16:34:21
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1369786 | Sagent Pharmaceuticals Inc. | SGNT | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1398936 | Vivo Ventures V Affiliates Fund, L.p. | 575 High Street. Suite 201 Palo Alto CA 94301 | No | No | Yes | No | |
1398937 | Vivo Ventures Fund V, L.p. | 575 High Street, Suite 201 Palo Alto CA 94301 | No | No | Yes | No | |
1399028 | Vivo Ventures V, Llc | 575 High Street, Suite 201 Palo Alto CA 94301 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2016-04-21 | 1,982 | $13.55 | 2,978,803 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2016-04-21 | 23 | $13.55 | 34,961 | No | 4 | S | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.55 to $13.57 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- Includes 2,978,803 shares held of record by Vivo Ventures Fund V, L.P. ("Fund V") .Vivo Ventures V, LLC, the sole general partner of Fund V, may be deemed to be the beneficial owner of the shares held by Fund V. Vivo Ventures V, LLC hereby disclaims any beneficial ownership of any shares directly held by Fund V, except to the extent of its pecuniary interest therein.
- Includes 34,961 shares held of record by Vivo Ventures V Affiliates Fund, L.P. ("V Affiliates Fund"). Vivo Ventures V, LLC, the sole general partner of V Affiliates Fund, may be deemed to be the beneficial owner of the shares held by V Affiliates Fund. Vivo Ventures V, LLC hereby disclaims any beneficial ownership of any shares directly held by V Affiliates Fund, except to the extent of its pecuniary interest therein.